These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6201933)

  • 1. Biological response modifiers and their promise in clinical medicine.
    Attallah AM; Yeatman TJ; Johnson RP; Petricciani JC
    Pharmacol Ther; 1982; 19(3):435-54. PubMed ID: 6201933
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunotherapy today. II. Immunostimulating therapy].
    D'Amelio R
    Riv Med Aeronaut Spaz; 1978; 41(1):75-114. PubMed ID: 93770
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results and prospects of using thymosin for the purpose of regulating the immune system in different pathological processes and states].
    Grinevich IuA; Kamenets LIa
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):9-15. PubMed ID: 390944
    [No Abstract]   [Full Text] [Related]  

  • 4. Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer.
    Goldstein AL
    Antibiot Chemother (1971); 1978; 24():47-59. PubMed ID: 350140
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunopharmacologic bases of immunotherapy.
    Hadden JW; Keskiner Merriam L
    Clin Physiol Biochem; 1985; 3(2-3):111-9. PubMed ID: 2408810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thymic hormones. Neuroendocrine interactions and clinical use in congenital and acquired immune deficiencies].
    Martin-Du-Pan RC
    Ann Endocrinol (Paris); 1984; 45(6):355-68. PubMed ID: 6399194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymosin: basic properties and clinical application in the treatment of immunodeficiency diseases and cancer.
    Marshall GD; Thurman GB; Low TL; Goldstein AL
    Recent Results Cancer Res; 1980; 75():100-5. PubMed ID: 6262885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymosin for immunodeficiency diseases and cancer.
    Goldstein AL; Rossio JL
    Compr Ther; 1978 Feb; 4(2):49-57. PubMed ID: 624213
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic reconstitution of patients with primary immunodeficiency diseases and cancer after treatment with thymosin.
    Goldstein AL; Thurman GB; Rossio JL; Costanzi JJ
    Transplant Proc; 1977 Mar; 9(1):1141-4. PubMed ID: 325742
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic products as immunomodulators].
    Sakiyama Y
    Nihon Rinsho; 1981 Apr; 39(4):1914-20. PubMed ID: 6171656
    [No Abstract]   [Full Text] [Related]  

  • 11. Overview of thymosin activity.
    Marshall GD; Low TL; Thurman GB; Hu SK; Rossio JL; Trivers G; Goldstein AL
    Cancer Treat Rep; 1978 Nov; 62(11):1731-7. PubMed ID: 215305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic factors.
    Bach JF; Carnaud C
    Prog Allergy; 1976; 21():342-408. PubMed ID: 12517
    [No Abstract]   [Full Text] [Related]  

  • 13. Thymic peptide hormones: basic properties and clinical applications in cancer.
    Schulof RS
    Crit Rev Oncol Hematol; 1985; 3(4):309-76. PubMed ID: 3902261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
    Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
    Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
    [No Abstract]   [Full Text] [Related]  

  • 15. Thymic function in man.
    Pahwa R; Ikehara S; Pahwa SG; Good RA
    Thymus; 1979 Sep; 1(1-2):27-58. PubMed ID: 317931
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymic humoral factor (THF) therapy in a patient with Di-George syndrome.
    Ersoy F; Sanal O; Yeğin O; Berkel AI; Cağlar M
    Turk J Pediatr; 1982; 23(2):115-20. PubMed ID: 7201177
    [No Abstract]   [Full Text] [Related]  

  • 17. Thymosin and the endocrine thymus.
    Schulof RS; Goldstein AL
    Adv Intern Med; 1977; 22():121-43. PubMed ID: 320839
    [No Abstract]   [Full Text] [Related]  

  • 18. Research with immunoactive agents.
    Gunby P
    JAMA; 1981 Jul; 246(3):205. PubMed ID: 7017181
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical application of transfer factor, lymphokines and thymic factor].
    Hori M
    Nihon Rinsho; 1983; 41(4):857-67. PubMed ID: 6350654
    [No Abstract]   [Full Text] [Related]  

  • 20. T-cell stimulator undergoes diverse testing.
    Gunby P
    JAMA; 1982 Aug; 248(7):807. PubMed ID: 7047781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.